Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02622282 · ClinicalTrials.gov registry record · NA
Text Messaging to Promote Walking Among Latino Adults at Risk for Peripheral Arterial Disease
A NA study, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 69
- Enrollment target
NCT02622282 is a NA study that has completed, run by University of Kansas Medical Center. The registered enrollment target is 69 participants.
The verdict
NCT02622282, a NA study, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 69 participants
- Enrollment target
Study Summary
The purpose of this study is to learn about the impact of text messaging on physical activity in persons with risk factors for peripheral arterial disease (PAD).
Interventions
- OTHER Phone Calls
- OTHER Text Messages
- OTHER Handout
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2016-05 |
| Est. Completion | 2016-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02622282
The ClinicalTrials.gov registry entry for NCT02622282 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Phone Calls is the first listed.
NCT02622282 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02622282 about?
NCT02622282 is a clinical study titled "Text Messaging to Promote Walking Among Latino Adults at Risk for Peripheral Arterial Disease". The purpose of this study is to learn about the impact of text messaging on physical activity in persons with risk factors for peripheral arterial disease (PAD).
What is the current status of trial NCT02622282?
This trial is currently completed. It is a NA study. The enrollment target is 69 participants. The study started on 2016-05. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02622282?
The interventions under investigation include: Phone Calls (OTHER), Text Messages (OTHER), Handout (OTHER).
Who is sponsoring clinical trial NCT02622282?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.